Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Preoperative CHG Cloth (2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02291601
Recruitment Status : Completed
First Posted : November 14, 2014
Last Update Posted : December 8, 2015
Sponsor:
Information provided by (Responsible Party):
Medline Industries

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Demonstrate the reduction of bacteria on the skin.

Condition or disease Intervention/treatment Phase
Surgical Skin Preparation Drug: Chlorhexidine Gluconate Other: Vehicle Drug: 2% Chlorhexidine Gluconate Solution Phase 3

Detailed Description:
Examine the antimicrobial cloth effects on bacteria of the abdomen and groin area.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 879 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation
Study Start Date : October 2014
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Chlorhexidine Gluconate Cloth
2% CHG, single application
 Drug: Chlorhexidine Gluconate
comparison with other CHG products
Placebo Comparator: Vehicle Cloth
Excipients on cloth
 Other: Vehicle
Cloth with Excipients no CHG
Active Comparator: Active Chlorhexidine gluconate solution
Dynahex 2% CHG
 Drug: 2% Chlorhexidine Gluconate Solution
CHG solution
Other Name: DynaHex


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Count the number of bacteria on skin [ Time Frame: 10 minutes to 8 hours ]
    Bacteria on the skin will be evaluated at time 0, 10 minutes, 6 hours and 8 hours after treatment.


Secondary Outcome Measures :
  1. Assess the side effects on the skin [ Time Frame: 10 min to 8 hours ]
    Treated skin will be assessed for any irritation.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Males or Females
  • 16 years of age or older
  • Signed informed consent
  • Good Health
  • Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion Criteria:

  • Dermatological Conditions
  • Sensitivity to latex
  • Sensitivity to CHG
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02291601


Locations
Layout table for location information
United States, Montana
BioScience
Butte, Montana, United States, 59701
Sponsors and Collaborators
Medline Industries
Investigators
Layout table for investigator information
Principal Investigator: C Beausoleil BS
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Medline Industries
ClinicalTrials.gov Identifier: NCT02291601    
Other Study ID Numbers: R13-052
First Posted: November 14, 2014    Key Record Dates
Last Update Posted: December 8, 2015
Last Verified: December 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Chlorhexidine
Chlorhexidine gluconate
Anti-Infective Agents, Local
 Anti-Infective Agents
Disinfectants
Dermatologic Agents